I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ugradar, Shoaib
47
results:
Search for persons
X
Format
Online (47)
Mediatypes
Articles (Online) (41)
OpenAccess-fulltext (6)
Sorted by: Relevance
Sorted by: Year
?
1
Teprotumumab improves light sensitivity in patients with th..:
Parunakian, Emanuil
;
Ugradar, Shoaib
;
Tolentino, Joseph
...
Graefe's Archive for Clinical and Experimental Ophthalmology. , 2024
Link:
https://doi.org/10.1007/..
?
2
Teprotumumab for the treatment of Thyroid eye disease:
Ugradar, Shoaib
;
Malkhasyan, Emil
;
Douglas, Raymond S
Endocrine Reviews. , 2024
Link:
https://doi.org/10.1210/..
?
3
The Rate of Retreatment in Patients treated with teprotumum..:
Ugradar, Shoaib
;
Parunakian, Emanuil
;
Malkhasyan, Emil
...
Ophthalmology. , 2024
Link:
https://doi.org/10.1016/..
?
4
#1706739 Efficacy of Teprotumumab in Phenotype Type I vs Ty..:
Cukovic, Lejla
;
Cukovic, Lejla
;
Ugradar, Shoaib
...
Endocrine Practice. 30 (2024) 5 - p. S161 , 2024
Link:
https://doi.org/10.1016/..
?
5
Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Ant..:
Moster, Mark
;
Douglas, Raymond
;
Cockerham, Kimberly
...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023
Link:
https://doi.org/10.1212/..
?
6
Efficacy and Safety of Teprotumumab in Patients With Thyroi..:
Douglas, Raymond S
;
Couch, Steven
;
Wester, Sara T
...
The Journal of Clinical Endocrinology & Metabolism. 109 (2023) 1 - p. 25-35 , 2023
Link:
https://doi.org/10.1210/..
?
7
The Management of Lumps, Bumps, and Contour Irregularities ..:
Ugradar, Shoaib
;
Wang, Yao
;
Patel, Amy
...
Aesthetic Surgery Journal. 43 (2023) 6 - p. 633-642 , 2023
Link:
https://doi.org/10.1093/..
?
8
The effects of topical oxymetazoline on eyelid position, ey..:
Shoji, Marissa K.
;
Markatia, Zahra
;
Ameli, Kambiz
...
Journal of Plastic, Reconstructive & Aesthetic Surgery. 80 (2023) - p. 66-74 , 2023
Link:
https://doi.org/10.1016/..
?
9
FRI545 Durability Of Treatment Response With VRDN-001, A Fu..:
Douglas, Raymond
;
Ugradar, Shoaib
;
Cockerham, Kimberley
...
Journal of the Endocrine Society. 7 (2023) Supplement_1 - p. , 2023
Link:
https://doi.org/10.1210/..
?
10
Change in lacrimal gland volume and aqueous tear production..:
Ugradar, Shoaib
;
Zimmerman, Erin
;
Parunakian, Emanuil
...
Clinical & Experimental Ophthalmology. 51 (2023) 4 - p. 339-348 , 2023
Link:
https://doi.org/10.1111/..
?
11
Commentary on "A Quantitative Three-Dimensional Tear Trough..:
Massry, Guy
;
Ugradar, Shoaib
Aesthetic Plastic Surgery. 47 (2023) 6 - p. 2461-2462 , 2023
Link:
https://doi.org/10.1007/..
?
12
Teprotumumab Efficacy, Safety, and Durability in Longer-Dur..:
Douglas, Raymond S.
;
Kahaly, George J.
;
Ugradar, Shoaib
...
Ophthalmology. 129 (2022) 4 - p. 438-449 , 2022
Link:
https://doi.org/10.1016/..
?
13
Changing the face of thyroid eye disease:
Ugradar, Shoaib
;
Goldberg, Robert A.
;
Douglas, Raymond S.
Eye. 37 (2022) 2 - p. 197-199 , 2022
Link:
https://doi.org/10.1038/..
?
14
RF35 | PSAT268 Reversal of Graves' Disease Associated Facia..:
Ugradar, Shoaib
;
Douglas, Raymond
Journal of the Endocrine Society. 6 (2022) Supplement_1 - p. A861-A862 , 2022
Link:
https://doi.org/10.1210/..
?
15
Expert Consensus on the Use of Teprotumumab for the Managem..:
Douglas, Raymond S.
;
Kossler, Andrea L.
;
Abrams, Jody
...
Journal of Neuro-Ophthalmology. 42 (2022) 3 - p. 334-339 , 2022
Link:
https://doi.org/10.1097/..
1-15